| Structure | Chemical Name | CAS | MF |
|
2-Fluoro-N-(2-fluoro-4-chlorophenyl)benzaMide, 97%
|
545440-44-6
|
C13H8ClF2NO
|
|
3-(3,4-DIHYDROXY-PHENYL)-PROPIONALDEHYDE
|
545442-98-6
|
C9H10O3
|
|
3,3-Dichloro-1-(4-iodophenyl)piperidin-2-one
|
545445-10-1
|
C11H10Cl2INO
|
|
Pyridine, 3-[(1E)-3-(aminooxy)-1-propenyl]- (9CI)
|
545445-34-9
|
C8H10N2O
|
|
3-Morpholin-4-yl-5,6-dihydro-1H-pyridin-2-one
|
545445-40-7
|
C9H14N2O2
|
|
3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
|
545445-44-1
|
C20H25N3O3
|
|
Benzeneacetaldehyde, 4-(5-ethyl-2-pyrimidinyl)- (9CI)
|
545445-67-8
|
C14H14N2O
|
|
Carbonic acid, (2,2-diethyl-1,3-dioxolan-4-yl)methyl methyl ester (9CI)
|
545517-65-5
|
C10H18O5
|
|
Carbonic acid, ethyl (2-ethyl-2-methyl-1,3-dioxolan-4-yl)methyl ester (9CI)
|
545517-68-8
|
C10H18O5
|
|
Carbonic acid, (2-ethyl-2-methyl-1,3-dioxolan-4-yl)methyl methyl ester (9CI)
|
545517-71-3
|
C9H16O5
|
|
Carbonic acid, ethyl (2-ethyl-1,3-dioxolan-4-yl)methyl ester (9CI)
|
545517-77-9
|
C9H16O5
|
|
Carbonic acid, 2,2-diethyl-1,3-dioxan-5-yl methyl ester (9CI)
|
545517-98-4
|
C10H18O5
|
|
Carbonic acid, ethyl 2-ethyl-1,3-dioxan-5-yl ester (9CI)
|
545518-23-8
|
C9H16O5
|
|
Carbonic acid, 2-ethyl-2-methyl-1,3-dioxan-5-yl methyl ester (9CI)
|
545518-29-4
|
C9H16O5
|
|
Carbonic acid, ethyl 2-ethyl-2-methyl-1,3-dioxan-5-yl ester (9CI)
|
545518-32-9
|
C10H18O5
|
|
1,3-Dioxolane,4-(ethoxymethyl)-2-ethyl-2-propyl-(9CI)
|
545581-74-6
|
C11H22O3
|
|
1,3-Dioxane,5-ethoxy-2,2-dimethyl-(9CI)
|
545581-96-2
|
C8H16O3
|
|
1,3-Dioxane,5-ethoxy-2-ethyl-(9CI)
|
545581-99-5
|
C8H16O3
|
|
1,3-Dioxane,2-ethyl-5-methoxy-2-methyl-(9CI)
|
545582-05-6
|
C8H16O3
|
|
1,3-Dioxane,5-methoxy-2-propyl-(9CI)
|
545582-14-7
|
C8H16O3
|
|
1,3-Dioxane,5-ethoxy-2-ethyl-2-propyl-(9CI)
|
545582-29-4
|
C11H22O3
|
|
1,3-Dioxane,5-ethoxy-2,2-dipropyl-(9CI)
|
545582-38-5
|
C12H24O3
|
|
5,8-Dioxaspiro[3.4]octane-2-Methanol
|
545882-60-8
|
C7H12O3
|
|
2-(QUINAZOLIN-4-YLTHIO)PROPANOIC ACID
|
546062-56-0
|
C11H10N2O2S
|
|
3-(2,6-DICHLOROPHENYL)-5-METHYLISOXAZOL-4-YL 4-PYRIMIDIN-2-YLPIPERAZINYL KETONE
|
546062-79-7
|
C19H17Cl2N5O2
|
|
AKOS B015580
|
546064-43-1
|
C12H15ClN2O4S
|
|
Cyclopentanecarboxamide, N-2-propenyl- (9CI)
|
546064-70-4
|
C9H15NO
|
|
4-(4-broMophenyl)-2-(2-cyano-acetylaMino)-thiophene-3-carboxylic acid ethyl ester
|
546064-73-7
|
C16H13BrN2O3S
|
|
N-(2-Fluoro-4-chlorophenyl)-3-MethylbenzaMide, 97%
|
546067-98-5
|
C14H11ClFNO
|
|
5-Thiazolecarboxamide,2-[(cyclopropylcarbonyl)amino]-N,N,4-trimethyl-(9CI)
|
546071-40-3
|
C11H15N3O2S
|
|
2-(2-CYANO-ACETYLAMINO)-4-P-TOLYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
|
546071-64-1
|
C17H16N2O3S
|
|
Pyrazinecarboxamide, N-(2-methyl-4-nitrophenyl)- (9CI)
|
546072-02-0
|
C12H10N4O3
|
|
2-Furancarboxamide,tetrahydro-N-(2-methyl-4-nitrophenyl)-(9CI)
|
546072-35-9
|
C12H14N2O4
|
|
3-Furancarboxamide,2-methyl-N-(2-methyl-4-nitrophenyl)-(9CI)
|
546073-77-2
|
C13H12N2O4
|
|
Piperazine, 1-ethyl-4-(1-oxobutyl)- (9CI)
|
546077-37-6
|
C10H20N2O
|
|
Piperazine, 1-(dichloroacetyl)-4-ethyl- (9CI)
|
546079-37-2
|
C8H14Cl2N2O
|
|
Cyclopentanecarboxamide, N-[2-methyl-6-(1-methylethyl)phenyl]- (9CI)
|
546079-70-3
|
C16H23NO
|
|
2-Furancarboxamide,5-methyl-N-(4-methyl-2-nitrophenyl)-(9CI)
|
546079-85-0
|
C13H12N2O4
|
|
Pyrazinecarboxamide, N-2-propenyl- (9CI)
|
546080-00-6
|
C8H9N3O
|
|
2-Furancarboxamide,tetrahydro-N-[2-methyl-6-(1-methylethyl)phenyl]-(9CI)
|
546080-28-8
|
C15H21NO2
|
|
Piperazine, 1-ethyl-4-[(2-methyl-3-furanyl)carbonyl]- (9CI)
|
546081-66-7
|
C12H18N2O2
|
|
4-Fluoro-N-(2-fluoro-4-chlorophenyl)benzaMide, 97%
|
546082-82-0
|
C13H8ClF2NO
|
|
2-[4-(4-Nitrobenzoyl)piperazin-1-yl]pyrimidine
|
546083-14-1
|
C15H15N5O3
|
|
L-glycero-L-galacto-Nonitol, 2,6-anhydro-7,8,9-trideoxy-8-methyl- (9CI)
|
546084-21-3
|
C10H20O5
|
|
(1R,2R)-[1,2-Cyclohexanediamino-N,N'-bis(4-bromobenzyl)allylchlorosilane,min.98%
|
546084-25-7
|
C23H27Br2ClN2Si
|
|
1H-Pyrrolizine-7a(5H)-carbonitrile,tetrahydro-1,7-dimethyl-,(1R,7R)-rel-(9CI)
|
546084-65-5
|
C10H16N2
|
|
2,8-diazaspiro[4.5]decan-1-one
|
546086-95-7
|
C8H14N2O
|
|
Piperazine, 1-(cyclopentylcarbonyl)-4-ethyl- (9CI)
|
546090-48-6
|
C12H22N2O
|
|
2-cyano-N-(4-{[(3,4-dimethylisoxazol-5-yl)amino]sulfonyl}phenyl)acetamide
|
546090-57-7
|
C14H14N4O4S
|
|
2-(2-CYANO-ACETYLAMINO)-4-PHENYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
|
546090-58-8
|
C16H14N2O3S
|
|
Piperazine, 1-ethyl-4-(2-furanylcarbonyl)- (9CI)
|
546090-65-7
|
C11H16N2O2
|
|
2-Furancarboxamide,tetrahydro-N-2-propenyl-(9CI)
|
546091-07-0
|
C8H13NO2
|
|
5-HYDROXY-2-(4-METHYL-PIPERAZINE-1-CARBONYL)-CHROMEN-4-ONE
|
546093-05-4
|
C15H16N2O4
|
|
5-HYDROXY-4-OXO-4H-CHROMENE-2-CARBOXYLIC ACID 4-CHLORO-BENZYLAMIDE
|
546093-13-4
|
C17H12ClNO4
|
|
Cyclohexanamine, 4,4-difluoro-N-methyl- (9CI)
|
546093-43-0
|
C7H13F2N
|
|
2,8-Diazaspiro[4.5]decan-1-one, 2-Methyl-
|
546093-44-1
|
C9H16N2O
|
|
2-(Dimethylamino)ethyl 2-methyl-2-propenoate telomer with ethenylbenzene, 2-hydroxyethyl 2-methyl-2-propenoate, isooctyl 3-mercaptopropanoate and α-(2-methyl-1-oxo-2-propenyl)-ω-methoxypoly(oxy-1,2-ethanediyl), 2,2'-[azobis(1-methylethylidene)]bis[4,5-dih
|
546093-73-6
|
|
|
OctanaMide, N-(3-Methylbutyl)-
|
546098-90-2
|
C13H27NO
|
|
Cyclopropanecarboxamide, N-(1-methylpropyl)- (9CI)
|
546099-60-9
|
C8H15NO
|
|
methyl 2-[(cyanoacetyl)amino]-4-phenylthiophene-3-carboxylate
|
546099-80-3
|
C15H12N2O3S
|
|
Piperazine, 1-ethyl-4-(pyrazinylcarbonyl)- (9CI)
|
546099-98-3
|
C11H16N4O
|
|
Cdk4 Inhibitor
|
546102-60-7
|
C20H10BrN3O2
|
|
H-Pro-Arg-AMC . 2 HCl
|
546103-85-9
|
C21H28N6O4
|
|
Piperazine, 1-ethyl-4-(2-ethyl-1-oxobutyl)- (9CI)
|
546104-87-4
|
C12H24N2O
|
|
N-(2-Fluoro-4-chlorophenyl)-4-MethylbenzaMide, 97%
|
546106-19-8
|
C14H11ClFNO
|
|
Benzamide, 4-ethoxy-N-2-propenyl- (9CI)
|
546106-37-0
|
C12H15NO2
|
|
1-(4-(2-FLUOROPHENYL)PIPERAZINYL)-3-PHENYLPROP-2-EN-1-ONE
|
546107-80-6
|
C19H19FN2O
|
|
Piperazine, 1-ethyl-4-(3-methyl-1-oxobutyl)- (9CI)
|
546109-11-9
|
C11H22N2O
|
|
Litronesib (Racemate)
|
546111-97-1
|
C23H37N5O4S2
|
|
Hydrazinecarbothioamide, 2-[1-(3,5-dihydroxyphenyl)ethylidene]- (9CI)
|
546112-30-5
|
C9H11N3O2S
|
|
Hydrazinecarbothioamide, 2-[1-(3,4-dihydroxyphenyl)ethylidene]- (9CI)
|
546112-31-6
|
C9H11N3O2S
|
|
Benzenamine, 3-ethyl-4-[(trimethylsilyl)ethynyl]- (9CI)
|
546112-58-7
|
C13H19NSi
|
|
4-Azaspiro[2.5]octan-5-one(9CI)
|
546114-04-9
|
C7H11NO
|
|
2-Pyrrolidinemethanamine,N,1-diethyl-,(2S)-(9CI)
|
546114-75-4
|
C9H20N2
|
|
1,3-Propanediamine,N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-N,N-dimethyl-(9CI)
|
546114-78-7
|
C12H27N3
|
|
(S)-methyl 3-(3-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate
|
546115-43-9
|
C15H20BrNO4
|
|
1-(3-BROMOPHENYL)CYCLOPROPANAMINE
|
546115-65-5
|
C9H10BrN
|
|
Piperazine,1-(chloroacetyl)-4-ethyl-
|
546116-23-8
|
C8H15ClN2O
|
|
2-CHLORO-1-[4-(2-FLUORO-PHENYL)-PIPERAZIN-1-YL]-ETHANONE
|
546116-24-9
|
C12H14ClFN2O
|
|
2-(2-CHLORO-ACETYLAMINO)-5-DIMETHYLCARBAMOYL-4-METHYL-THIOPHENE-3-CARBOXYLIC ACID ETHYL ESTER
|
546116-25-0
|
C13H17ClN2O4S
|
|
Cyclopropanecarboxamide, N-(3-methylbutyl)- (9CI)
|
546116-33-0
|
C9H17NO
|
|
2,4-DIFLUOROBENZYLMAGNESIUM BROMIDE
|
546122-71-8
|
C7H5BrF2Mg
|
|
Bicyclo[3.2.1]oct-2-ene-2-methanol, 6-(methoxymethoxy)-, (1R,5S,6R)- (9CI)
|
546125-86-4
|
C11H18O3
|
|
2(3H)-Furanone,5-[[(4R)-2,2-diethyl-1,3-dioxolan-4-yl]methyl]dihydro-,(5S)-(9CI)
|
546127-27-9
|
C12H20O4
|
|
1H-1,5-Benzodiazepine,2,4-diethyl-2,3-dihydro-2,8-dimethyl-(9CI)
|
546127-60-0
|
C15H22N2
|
|
N-Cyclohexylcarbamic acid [1,1'-biphenyl]-3-yl ester
|
546141-07-5
|
C19H21NO2
|
|
URB597
|
546141-08-6
|
C20H22N2O3
|
|
2,3-O-cyclohexylidene-(L)-Lyxonic acid γ-lactone
|
546141-19-9
|
C11H16O5
|
|
D-glycero-D-gulo-Dec-1-enitol, 4,7-anhydro-1,2,3,8-tetradeoxy-6-O-(phenylmethyl)-, 9,10-dibenzoate
|
546141-24-6
|
C31H32O7
|
|
(S)-3-((2R,3R,4R,5S)-5-allyl-3-hydroxy-4-((phenylsulfonyl)methyl)tetrahydrofuran-2-yl)propane-1,2-diyl dibenzoate
|
546141-26-8
|
C31H32O8S
|
|
a-D-xylo-Hept-6-enofuranose, 5,6,7-trideoxy-1,2-O-(1-Methylethylidene)-
|
546141-37-1
|
C10H16O4
|
|
2-Pyridinecarboxylicacid,5-amino-3,6-dichloro-(9CI)
|
546141-54-2
|
C6H4Cl2N2O2
|
|
4-amino-6-chloropicolinic acid
|
546141-56-4
|
C6H5ClN2O2
|
|
3-(4-BroMo-1H-pyrazol-1-yl)benzonitrile
|
546142-07-8
|
C10H6BrN3
|
|
3-(4-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)benzonitrile
|
546142-08-9
|
C16H18BN3O2
|
|
7H-Pyrano[2,3-g]benzothiazol-7-one, 2-amino-4,9-dimethyl-
|
546144-86-9
|
C12H10N2O2S
|
|
7H-Pyrano[2,3-g]benzothiazol-7-one, 2-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-4,9-dimethyl-
|
546144-87-0
|
C15H9Cl2N5O2S
|
|
Thiourea, N-[4-chloro-6-[(4,9-dimethyl-7-oxo-7H-pyrano[2,3-g]benzothiazol-2-yl)amino]-1,3,5-triazin-2-yl]-N-(4,7-dimethyl-2-oxo-2H-1-benzopyran-6-yl)-
|
546144-89-2
|
C27H20ClN7O4S2
|
|
Thiourea, N,N-[6-[(4,9-dimethyl-7-oxo-7H-pyrano[2,3-g]benzothiazol-2-yl)amino]-1,3,5-triazine-2,4-diyl]bis[N-(4,7-dimethyl-2-oxo-2H-1-benzopyran-6-
|
546144-90-5
|
C39H31N9O6S3
|
|
N-(2-AMinoethyl)-2-(5-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)acetaMide
|
546145-03-3
|
C9H14N4O3
|